KyungdongPharm Logo

KyungdongPharm

Develops and manufactures Rx/OTC drugs & APIs for cardiology and other chronic conditions.

011040 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 양감면 제약단지로 224-3, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1975, Kyung Dong Pharm is a pharmaceutical company specializing in the development, manufacturing, and sale of medical treatments. The company produces a diverse portfolio of prescription medicines, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). Its core therapeutic areas include cardiology, endocrinology, gastroenterology, and urology, with a focus on treatments for conditions such as diabetes, hypertension, and hyperlipidemia. A key consumer product is the well-known OTC painkiller, 'Geunal-en'. Utilizing advanced manufacturing facilities and proprietary technology, Kyung Dong Pharm is committed to expanding its R&D pipeline and growing its global presence through exports.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KyungdongPharm and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-10 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.9 KB
2025-09-01 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 29.7 KB
2025-08-27 00:00
Major Shareholding Notification
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Korean 30.0 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 250.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB

Automate Your Workflow. Get a real-time feed of all KyungdongPharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KyungdongPharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea 303360

Talk to a Data Expert

Have a question? We'll get back to you promptly.